{
  "Variants Include": [],
  "Described Disease": {
    "Described Disease": "Early-Onset Parkinson's Disease",
    "MONDO": "MONDO:0019687"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cancer Mutation Analysis",
      "Material used": {
        "Material Source": "Tumor samples/Cell lines derived from patients with EOPD",
        "Material Name": "Extracted tumor cells or cell lines",
        "Description": "Data from cancer tissue analysis."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Inactivating mutations in PARK2 were observed in patients with EOPD.",
          "Molecular Effect": "Abrogated growth-suppressive effects of the PARK2 protein.",
          "Result Description": "Specific oncogenic mutations were identified."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Information not provided in the literature abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the provided context."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No specific controls mentioned."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No specific controls mentioned."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "Not specified."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "Not specified."
      },
      "Statistical analysis method": "Statistical analysis of mutation frequencies and patterns.",
      "Threshold for normal readout": "N.D.",
      "Threshold for abnormal readout": "N.D.",
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}